Cartesian Therapeutics
RNAC
#8958
Rank
ยฃ0.14 B
Marketcap
ยฃ4.69
Share price
4.24%
Change (1 day)
-15.11%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): -ยฃ1.40

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.42. In 2021 the company made an earnings per share (EPS) of -ยฃ5.50 an increase over its 2020 EPS that were of -ยฃ15.82.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.40
2021-ยฃ5.50-65.22%
2020-ยฃ15.82-43.44%
2019-ยฃ27.98-58.08%
2018-ยฃ66.73-9.35%
2017-ยฃ73.61-29.16%
2016-ยฃ103.91